Publicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (18)

2023

  1. Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2

    Viruses, Vol. 15, Núm. 7

2022

  1. First confirmation of importation and transmission in Spain of the newly identified SARS-CoV-2 B.1.1.7 variant

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 40, Núm. 10, pp. 546-549

2021

  1. Fever without source as the first manifestation of SARS-CoV-2 infection in infants less than 90 days old

    European Journal of Pediatrics, Vol. 180, Núm. 7, pp. 2099-2106

2020

  1. Prolonged administration of maraviroc reactivates latent HIV in vivo but it does not prevent antiretroviral-free viral rebound

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Lower expression of plasma-derived exosome miR-21 levels in HIV-1 elite controllers with decreasing CD4 T cell count

    Journal of Microbiology, Immunology and Infection, Vol. 52, Núm. 4, pp. 667-671

2018

  1. Trends in Drug Resistance Prevalence, HIV-1 Variants and Clinical Status in HIV-1-infected Pediatric Population in Madrid: 1993 to 2015 Analysis

    Pediatric Infectious Disease Journal, Vol. 37, Núm. 3, pp. e48-e57

2016

  1. MicroRNA profile in CD8+ T-lymphocytes from HIV-infected individuals: Relationship with antiviral immune response and disease progression

    PLoS ONE, Vol. 11, Núm. 5

2015

  1. Transmitted drug resistance to rilpivirine in newly diagnosed antiretroviral naive adults

    Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 104.e1-104.e5

  2. Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012)

    Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 105.e1-105.e5

2013

  1. Detección de mutaciones de resistencia en ADN proviral en infección por VIH-1

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 31, Núm. SUPPL.1, pp. 35-39

2011

  1. Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain

    Journal of Antimicrobial Chemotherapy, Vol. 66, Núm. 10, pp. 2362-2371

  2. Molecular surveillance of HIV-1 in Madrid, Spain: A phylogeographic analysis

    Journal of Virology, Vol. 85, Núm. 20, pp. 10755-10763

2009

  1. Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and 2 nucleosides for maintenance therapy of HIV: 96-Week analysis

    Journal of Acquired Immune Deficiency Syndromes, Vol. 51, Núm. 2, pp. 147-152

  2. Risk factors for loss of virological suppression in patients receiving lopinavir/ritonavir monotherapy for maintenance of HIV suppression

    Antiviral Therapy, Vol. 14, Núm. 2, pp. 195-201

  3. The Chemokine Receptor CXCR4 and the Metalloproteinase MT1-MMP Are Mutually Required during Melanoma Metastasis to Lungs

    American Journal of Pathology, Vol. 174, Núm. 2, pp. 602-612

2008

  1. Long-term (4 years) efficacy of lopinavir/ritonavir monotherapy for maintenance of HIV suppression

    Journal of Antimicrobial Chemotherapy, Vol. 61, Núm. 6, pp. 1359-1361

  2. Structural requirements for multimerization of the pathogen receptor dendritic cell-specific ICAM3-grabbing non-integrin (CD209) on the cell surface

    Journal of Biological Chemistry, Vol. 283, Núm. 7, pp. 3889-3903

2007

  1. Diagnóstico microbiológico de la infección por el VIH

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 25, Núm. 10, pp. 632-638